Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence

Daniele Ghezzi, Carlo Viscomi, Alessandra Ferlini, Francesca Gualandi, Paolo Mereghetti, Domenico Degrandis, Massimo Zeviani

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Paroxysmal non-kinesigenic dyskinesia (PNKD) is an autosomal-dominant movement disorder characterized by attacks of dystonia, chorea and athetosis. Myofibrillogenesis regulator-1 (MR-1), the gene responsible for PNKD, is transcribed into three alternatively spliced forms: long (MR-1L), medium (MR-1M) and small (MR-1S). Two mutations, A7V and A9V, were previously discovered in the N-terminal region common to MR-1L and MR-1S. We now found a third mutation, A33P, in a new PNKD patient in the same region. Contrary to previous reports, we show here that the mutation-free MR-1M is localized in the Golgi apparatus, ER and plasma membrane, whereas both MR-1L and MR-1S isoforms are mitochondrial proteins, imported into the organelle thanks to a 39 amino acid-long, N-terminal mitochondrial targeting sequence (MTS). The MTS, which contains all three PNKD mutations, is then cleaved off the mature proteins before their insertion in the inner mitochondrial membrane. Therefore, mature MR-1S and MR-1L of PNKD patients are identical to those of normal subjects. We found no difference in import efficiency and protein maturation between wild-type and mutant MR-1 variants. These results indicate that PNKD is due to a novel disease mechanism based on a deleterious action of the MTS.

Original languageEnglish
Pages (from-to)1058-1064
Number of pages7
JournalHuman Molecular Genetics
Volume18
Issue number6
DOIs
Publication statusPublished - 2009

Fingerprint

Muscle Development
Mutation
Athetosis
Chorea
Dystonia
Mitochondrial Proteins
Movement Disorders
Mitochondrial Membranes
Golgi Apparatus
Regulator Genes
Organelles
Familial paroxysmal dystonia
Protein Isoforms
Proteins
Cell Membrane
Amino Acids

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Ghezzi, D., Viscomi, C., Ferlini, A., Gualandi, F., Mereghetti, P., Degrandis, D., & Zeviani, M. (2009). Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Human Molecular Genetics, 18(6), 1058-1064. https://doi.org/10.1093/hmg/ddn441

Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. / Ghezzi, Daniele; Viscomi, Carlo; Ferlini, Alessandra; Gualandi, Francesca; Mereghetti, Paolo; Degrandis, Domenico; Zeviani, Massimo.

In: Human Molecular Genetics, Vol. 18, No. 6, 2009, p. 1058-1064.

Research output: Contribution to journalArticle

Ghezzi, D, Viscomi, C, Ferlini, A, Gualandi, F, Mereghetti, P, Degrandis, D & Zeviani, M 2009, 'Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence', Human Molecular Genetics, vol. 18, no. 6, pp. 1058-1064. https://doi.org/10.1093/hmg/ddn441
Ghezzi, Daniele ; Viscomi, Carlo ; Ferlini, Alessandra ; Gualandi, Francesca ; Mereghetti, Paolo ; Degrandis, Domenico ; Zeviani, Massimo. / Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. In: Human Molecular Genetics. 2009 ; Vol. 18, No. 6. pp. 1058-1064.
@article{83084c507bef49e9b9f00580f25ec75e,
title = "Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence",
abstract = "Paroxysmal non-kinesigenic dyskinesia (PNKD) is an autosomal-dominant movement disorder characterized by attacks of dystonia, chorea and athetosis. Myofibrillogenesis regulator-1 (MR-1), the gene responsible for PNKD, is transcribed into three alternatively spliced forms: long (MR-1L), medium (MR-1M) and small (MR-1S). Two mutations, A7V and A9V, were previously discovered in the N-terminal region common to MR-1L and MR-1S. We now found a third mutation, A33P, in a new PNKD patient in the same region. Contrary to previous reports, we show here that the mutation-free MR-1M is localized in the Golgi apparatus, ER and plasma membrane, whereas both MR-1L and MR-1S isoforms are mitochondrial proteins, imported into the organelle thanks to a 39 amino acid-long, N-terminal mitochondrial targeting sequence (MTS). The MTS, which contains all three PNKD mutations, is then cleaved off the mature proteins before their insertion in the inner mitochondrial membrane. Therefore, mature MR-1S and MR-1L of PNKD patients are identical to those of normal subjects. We found no difference in import efficiency and protein maturation between wild-type and mutant MR-1 variants. These results indicate that PNKD is due to a novel disease mechanism based on a deleterious action of the MTS.",
author = "Daniele Ghezzi and Carlo Viscomi and Alessandra Ferlini and Francesca Gualandi and Paolo Mereghetti and Domenico Degrandis and Massimo Zeviani",
year = "2009",
doi = "10.1093/hmg/ddn441",
language = "English",
volume = "18",
pages = "1058--1064",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence

AU - Ghezzi, Daniele

AU - Viscomi, Carlo

AU - Ferlini, Alessandra

AU - Gualandi, Francesca

AU - Mereghetti, Paolo

AU - Degrandis, Domenico

AU - Zeviani, Massimo

PY - 2009

Y1 - 2009

N2 - Paroxysmal non-kinesigenic dyskinesia (PNKD) is an autosomal-dominant movement disorder characterized by attacks of dystonia, chorea and athetosis. Myofibrillogenesis regulator-1 (MR-1), the gene responsible for PNKD, is transcribed into three alternatively spliced forms: long (MR-1L), medium (MR-1M) and small (MR-1S). Two mutations, A7V and A9V, were previously discovered in the N-terminal region common to MR-1L and MR-1S. We now found a third mutation, A33P, in a new PNKD patient in the same region. Contrary to previous reports, we show here that the mutation-free MR-1M is localized in the Golgi apparatus, ER and plasma membrane, whereas both MR-1L and MR-1S isoforms are mitochondrial proteins, imported into the organelle thanks to a 39 amino acid-long, N-terminal mitochondrial targeting sequence (MTS). The MTS, which contains all three PNKD mutations, is then cleaved off the mature proteins before their insertion in the inner mitochondrial membrane. Therefore, mature MR-1S and MR-1L of PNKD patients are identical to those of normal subjects. We found no difference in import efficiency and protein maturation between wild-type and mutant MR-1 variants. These results indicate that PNKD is due to a novel disease mechanism based on a deleterious action of the MTS.

AB - Paroxysmal non-kinesigenic dyskinesia (PNKD) is an autosomal-dominant movement disorder characterized by attacks of dystonia, chorea and athetosis. Myofibrillogenesis regulator-1 (MR-1), the gene responsible for PNKD, is transcribed into three alternatively spliced forms: long (MR-1L), medium (MR-1M) and small (MR-1S). Two mutations, A7V and A9V, were previously discovered in the N-terminal region common to MR-1L and MR-1S. We now found a third mutation, A33P, in a new PNKD patient in the same region. Contrary to previous reports, we show here that the mutation-free MR-1M is localized in the Golgi apparatus, ER and plasma membrane, whereas both MR-1L and MR-1S isoforms are mitochondrial proteins, imported into the organelle thanks to a 39 amino acid-long, N-terminal mitochondrial targeting sequence (MTS). The MTS, which contains all three PNKD mutations, is then cleaved off the mature proteins before their insertion in the inner mitochondrial membrane. Therefore, mature MR-1S and MR-1L of PNKD patients are identical to those of normal subjects. We found no difference in import efficiency and protein maturation between wild-type and mutant MR-1 variants. These results indicate that PNKD is due to a novel disease mechanism based on a deleterious action of the MTS.

UR - http://www.scopus.com/inward/record.url?scp=61849106125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849106125&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddn441

DO - 10.1093/hmg/ddn441

M3 - Article

VL - 18

SP - 1058

EP - 1064

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 6

ER -